Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The efficacy and safety, as well as subject satisfaction will be evaluated after single
treatment with Azzalure/Dysport alone or Restylane/Emervel filler alone followed by repeated
combined treatment with Azzalure/Dysport, Restylane/Emervel filler and Restylane Skinbooster.
Subjects will be followed for up to 18 months after initial treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Q-Med AB
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A Hyaluronic Acid incobotulinumtoxinA onabotulinumtoxinA